Sandu Pharmaceuticals Ltd has informed that the Board of Directors at their Meeting held on February 14, 2022 have approved incorporation of a wholly owned subsidiary of the Company.
As per regulatory filing, the name of the subsidiary is Sandu Phytoceuticals Private Limited or any other name as may be approved by Ministry of Corporate Affairs. Proposed Authorized Capital is Rs1 lakh only.
Further, the Incorporation of the wholly owned subsidiary will leverage the growth opportunities and will help the Company in becoming more broad based and focused, said company on Monday.
At around 11:30 AM, Sandu Pharmaceuticals was trading at Rs57.10 apiece down by Rs0.45 or 0.78% against its previous closing of Rs57.55 apiece on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
